SEC Form 4 · accession 0001128732-15-000001
Sunshine Biopharma Inc. · SBFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve N. Slilaty
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jan 9, 2015
Accepted (ET)
Jan 22, 2015 · 11:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402328
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 9, 2015 | J | 1,200,000 | $0.02 | D | 30,317,694 | I | Owned by Advanomics Corporation, an entity controlled by Reporting Person. |
| Common StockF2 | Jan 9, 2015 | J | 150,000 | $0.02 | A | 384,373 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Advanomics Corporation, an entity controlled by Reporting Person, acquired intellectual properties in exchange for the transfer of 1,200,000 shares of the Issuer's Common Stock to 5 entities or persons, 150,000 shares of which having been transferred to the Reporting Person in the transaction. See Footnote 2.
- F2Reporting Person acquired 150,000 shares of the Issuer's Common Stock from Advanomics Corporation, an entity controlled by the Reporting Person, in exchange for interests in intellectual properties transferred to Advanomics Corporation. See Footnote 1.